Australian Clinical Labs Limited (ACL)
Market Closed
ASX ASX Primary 716.69M Market Cap
- P/E Ratio
0% Div Yield
779,754 Volume
- Eps
Want to track ACL and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 75 days
| Name | Time | Cons. EPS | Eps |
|---|---|---|---|
| ACL Australian Clinical Labs Limited 23 Feb 2026 (In 2 months) | | - | - |
| ACL Australian Clinical Labs Limited 26 Aug 2025 | | - | 0.12 |
| ACL Australian Clinical Labs Limited 26 Feb 2025 | | - | - |
| ACL Australian Clinical Labs Limited 22 Oct 2024 | | - | - |
| ACL Australian Clinical Labs Limited 21 Aug 2024 | | - | - |
| ACL Australian Clinical Labs Limited 28 Feb 2024 | | - | - |
ACL Earnings Reports FAQ
What is the earnings per share (EPS) for ACL?
EPS data for ACL is currently not available, as Australian Clinical Labs Limited has not reported recent earnings.
What is the company's earnings growth rate?
Australian Clinical Labs Limited has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.
When is the next earnings release date?
The next earnings release is expected to be on 2026-02-23, based on the ACL's typical earnings announcement schedule.
What were the most recent quarterly earnings?
The most recent quarterly earnings for Australian Clinical Labs Limited are not available at this time.
What is the price-to-earnings (P/E) ratio?
There is no P/E ratio for ACL at this time, as Australian Clinical Labs Limited has no recent EPS data to calculate it.
2025 © Marketlog. All Rights Reserved.
